Patents by Inventor Neil E. Stahl

Neil E. Stahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified ciliary neurotrophic factor (CNTF)
    Patent number: 7119066
    Abstract: Modified ciliary neurotrophic factor, methods for production and methods of use, especially in the treatment of Huntington's disease, obesity, and gestational or adult onset diabetes.
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: October 10, 2006
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: James P. Fandl, Neil E. Stahl, Stanley J. Wiegand
  • Modified ciliary neurotrophic factor, method of making and methods of use thereof
    Publication number: 20030144199
    Abstract: Modified ciliary neurotrophic factor, methods for production and methods of use, especially in the treatment of Huntington's disease, obesity, and gestational or adult onset diabetes.
    Type: Application
    Filed: October 28, 2002
    Publication date: July 31, 2003
    Inventors: James P. Fandl, Neil E. Stahl, Stanley J. Wiegand
  • Modified dorsal tissue affecting factor and compositions
    Publication number: 20030129703
    Abstract: Described are modified Noggin muteins, compositions comprising the muteins, and DNA or RNA sequences comprising coding (sense) or antisense sequences for the muteins.
    Type: Application
    Filed: December 19, 2002
    Publication date: July 10, 2003
    Inventors: Aris Economides, Neil E. Stahl, Richard M. Harland
  • Nucleic acid molecules encoding modified dorsal tissue affecting factor
    Patent number: 6500640
    Abstract: Described are modified Noggin muteins, compositions comprising the muteins, and DNA or RNA sequences comprising coding (sense) or antisense sequences for the muteins.
    Type: Grant
    Filed: February 8, 2000
    Date of Patent: December 31, 2002
    Assignees: Regeneron Pharmaceuticals, Inc., Regents of the University of California
    Inventors: Aris Economides, Neil E. Stahl, Richard M. Harland
  • Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
    Patent number: 6472178
    Abstract: Modified ciliary neurotrophic factor, methods for production and methods of use, especially in the treatment of Huntington's disease, obesity, and gestational or adult onset diabetes.
    Type: Grant
    Filed: February 27, 1998
    Date of Patent: October 29, 2002
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: James P. Fandl, Neil E. Stahl, Stanley J. Wiegand
  • Modified ciliary neurotrophic factor, method of making and methods of use thereof
    Publication number: 20020123462
    Abstract: Modified ciliary neurotrophic factor, methods for production and methods of use, especially in the treatment of Huntington's disease, obesity, and gestational or adult onset diabetes.
    Type: Application
    Filed: January 25, 2001
    Publication date: September 5, 2002
    Inventors: James P. Fandl, Neil E. Stahl, Stanley J. Wiegand
  • Modified noggin polypeptide and compositions
    Patent number: 6075007
    Abstract: Described are modified Noggin muteins, compositions comprising the muteins, and DNA or RNA sequences comprising coding (sense) or antisense sequences for the muteins.
    Type: Grant
    Filed: July 17, 1997
    Date of Patent: June 13, 2000
    Assignees: Regeneron Pharmaceuticals, Inc., Regents of the Univ. of California
    Inventors: Aris Economides, Neil E. Stahl, Richard M. Harland